Home Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
Article
Licensed
Unlicensed Requires Authentication

Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects

  • Ahmed Bakillah
Published/Copyright: December 5, 2008

Abstract

Background: Oxidative stress plays an important role in the pathogenesis of coronary artery disease. Recent work showed that high-density lipoproteins isolated from atherosclerotic lesions and blood of patients with established coronary artery disease contain elevated levels of nitrated apolipoprotein A-I. Methods to quantify nitrated apolipoprotein A-I in the plasma may facilitate in the determination of a correlation between plasma levels of nitrated apolipoprotein A-I and risk of atherosclerosis.

Methods: In this report, the presence of plasma nitrated apolipoprotein A-I in subjects with cardiovascular disease was detected by Western blot analysis and quantified by a newly developed specific sandwich enzyme-linked immunosorbent assay.

Results: The precision of the assay was indicated by the good correlation obtained between enzyme-linked immunosorbent assay and Western blot (r2=0.96). Using these two methods, we were able to detect significant elevations (3-fold increase) of plasma nitrated apolipoprotein A-I in low high-density lipoprotein cholesterol subjects as compared to high-density lipoprotein cholesterol subjects. In addition, we found that both plasma and serum samples can be used by enzyme-linked immunosorbent assay to quantify nitrated apolipoprotein A-I concentrations. More importantly, the degree of nitrated apolipoprotein A-I-containing high-density lipoprotein particles was negatively correlated with levels of circulating apolipoprotein A-I.

Conclusions: Measurement of nitrated apolipoprotein A-I levels by this rapid and reproducible new method has the advantages of great sensitivity with no sample manipulations, thus we suggest that this novel method could be useful to monitor levels of circulating nitrated apolipoprotein A-I in order to investigate its value as a potential biological marker for inflammatory vascular disease.

Clin Chem Lab Med 2009;47:60–9.


Corresponding author: Ahmed Bakillah, PhD, DSc, GlaxoSmithKline, R&D, 709 Swedeland Road, King of Prussia, PA 19406, USA Phone: +1-215-828-6481,

Received: 2008-5-30
Accepted: 2008-8-12
Published Online: 2008-12-05
Published Online: 2008-12-5
Published in Print: 2009-01-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Reviews
  2. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
  3. HIV-GB virus C co-infection: an overview
  4. Genetics and Molecular Diagnostics
  5. Relationships between C-reactive protein concentration and genotype in healthy volunteers
  6. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement
  7. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease
  8. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
  9. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
  10. Aging and endothelial progenitor cell telomere length in healthy men
  11. Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences
  12. Mutation screening of the medium-chain acyl-CoA dehydrogenase (MCAD) and the ornithine transcarbamylase (OTC) genes by multiplex PCR amplification and sequencing
  13. General Clinical Chemistry and Laboratory Medicine
  14. Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
  15. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
  16. Multi-elements (aluminium, copper, magnesium, manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively coupled plasma-mass spectrometry
  17. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients
  18. Validation and Outcome Studies
  19. Validation for quantification of immunoglobulins by Fourier transform infrared spectrometry
  20. Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method
  21. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme
  22. Verification of the analytical range of a new reagent for full-range C-reactive protein determination
  23. Measurement uncertainty in manual differential leukocyte counting
  24. Letters to the Editor
  25. Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report
  26. An unusual interference in parathormone assay caused by anti-goat IgG: a case report
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.017/html
Scroll to top button